The impact of genotype on endocrine complications in thalassaemia major

European Journal of Haematology

Volumn 77, Issue 2, 2006, Pages 150-156

  Skordis, Nicos ^a   Michaelidou, Monica ^a   Savva, Savvas C ^b   Ioannou, Yiannis ^a   Rousounides, Andreas ^a   Kleanthous, Marina ^c   Skordos, George ^a   Christou, Soteroulla ^a  

^a Archbishop Makarios III Hospital   (Cyprus)

^b Research and Education Institute of Child Health   (Cyprus)

^c CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

Author keywords

Endocrine complications; Genotype; Hypogonadism; Thalassaemia

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; FERRITIN; GLUCOSE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BONE DENSITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ENDOCRINE DISEASE; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GENETICS; GENOTYPE; GLUCOSE HOMEOSTASIS; GONAD FUNCTION; GREECE; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; INCIDENCE; INSULIN RESISTANCE; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PREVALENCE; PRIORITY JOURNAL; SHORT STATURE; SPLENECTOMY; STATISTICAL ANALYSIS; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; AGED; BETA-THALASSEMIA; BLOOD GLUCOSE; BLOOD TRANSFUSION; BONE DENSITY; BONE DISEASES, METABOLIC; CHELATION THERAPY; COMBINED MODALITY THERAPY; CYPRUS; DIABETES MELLITUS; DNA MUTATIONAL ANALYSIS; DWARFISM; ETHNIC GROUPS; FEMALE; FERRITINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOBINS; HUMANS; HYPOGONADISM; HYPOTHYROIDISM; INCIDENCE; INSULIN RESISTANCE; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; MALE; MENSTRUAL CYCLE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SPLENECTOMY;

EID: 33745713666     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00681.x     Document Type: Article

References (35)

1. DE SANCTIS V. Growth and puberty and its management in Thalassaemia. Horm Res 2002;58(Suppl. 1):72-79.
2. SKORDIS N. Endocrine complications in Cypriot Thalassaemic patients. In: ANDO S, BRANCATI C, eds. Endocrine Disorders in Thalassaemia. Heidenberg: Springer Verlag, 1995:83-89.
3. TIOSANO D, HOCHBERG Z. Endocrine complications of thalassaemia. J Endocrinol Invest 2001;24:716-723.
4. CHARTTEJEE R, KATZ M, COX TF. Prospective study of the hypothalamic-pituitary axis in thalassaemic patients who developed secondary amenorrhea. Clin Endocrinol 1993;39:278-296.
5. BERKOVITCH M, BISTRITZER T, MILONE S, PERIMAN K, KUCHARCZK W, KOREN G, OLIVIERI NF. Iron deposition in the anterior pituitary in homozygous beta-thalassaemia: MRI evaluation and correlation with gonadal function. J Pediatr Endocrinol Metab 2000;13:179-184.
6. OLIVIERI NF, NATHAN DG, MACMILLAN JH, WAYNE AS, LIU PP, MCGEE A, MARTIN M, KOREN G, COHEN AR. Survival in medically treated patients with homozygous β thalassaemia. N Engl J Med 1994;331:574-578.
7. JENSEN CE, TUCK SM, WONKE B. Fertility in beta thalassaemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literature. Br J Obstet Gynaecol 1995;102:625-629.
8. SKORDIS N, CHRISTOU S, KOLIOU M, PAVLIDES N, ANGASTINIOTIS M. Fertility in female thalassaemics. J Pediatr Endocrinol Metab 1998;11:935-943.
9. ANAPLIOTOU ML, KASTANIAS IT, PSARA P, EVANGELOU EA, LIPARAKI M, DIMITRIOU P. The contribution of hypogonadism to the development of osteoporosis in Thalassaemia major: new therapeutic approaches. Clin Endocrinol 1995;42:279-287.
10. OLIVIERI NF. Medical progress: the (beta)-thalassaemias. N Engl J Med 1999;341:99-109.
11. GRINGAS P, WONKE B, OLD J, FITCHES A, VALLER D, KUAN AM, HOFFBRAND V. Effect of α Thalassaemia trait and enhanced γ chain production on disease severity in β Thalassaemia major and intermedia. Arch Dis Child 1994;70:30-34.
12. JENSEN CE, TUCK CM, OLD J, MORRIS RW, YARDUMIAN A, DE SANCTIS V, HOFFBRAND AV, WONKE B. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with β-Thalassaemia. Eur J Haematol 1997;59:76-81.
13. TANNER JM, GOLDSTEIN H, WHITEHOUSE RH. Standards for children's height at ages 2-9 allowing for height of parents. Arch Dis Child 1970;45:755-762.
14. BAYSAL E, INDRAK K, BOZKURT G, et al. The β-Thalassaemia mutations in the population of Cyprus. Br J Haematol 1992;81:607-609.
15. KYRIACOU K, AL QUOBAILI F, PAVLOU E, CHRISTOPOULOS G, IOANNOU P, KLEANTHOUS M. Thalassaemia mutations found in Syria. Hemoglobin 2000;24:1-13.
16. BAYSAL E, KLEANTHOUS M, BOZKURT G, KYRRI A, KALOGIROU E, ANGASTINIOTIS M, IOANNOU P, HUISMAN THJ. α-Thalassaemia in the population of Cyprus. Br J Haematol 1995;89:496-499.
17. LIU YT, OLD JM, MILES K, FISHER CA, WEATHERALL DJ, CLEGG JB Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol 2000;108:295-299.
18. KYRIACOU K, KYRRI A, KALOGIROU E, VASILIADES P, ANGASTINIOTIS M, IOANNOU P, KLEANTHOUS M. Hemoglobin Bart's levels in cord blood and α-thalassaemia mutations in Cyprus. Hemoglobin 2000;24:171-180.
19. MOHAMMADIAN S, BAZRAFSHAN RH, SADEGHI-NAJAD A. Endocrine gland abnormalities in Thalassaemia major: a brief review. J Pediatr Endocrinol Metab 2003;16:957-964.
20. Italian Working Group on Endocrine Complications in Non-Endocrine Diseases. Multicentre study on prevalence of endocrine complications in Thalassaemia major. Clin Endocrinol 1995;42:581-586.
21. CHATTERJEE R, KATZ M. Reversible hypogonatotrophic hypogonadism in sexually infantile male Thalassaemia patients with transfusion iron overload. Clin Endocrinol 2000;53:33-42.
22. BRONSPIEGEL-WEINTROB N, OLIVIERI NF, TYLER B, ANDREWS DF, FREEDMAN MH, HOLLAND FJ. Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassaemia major. N Engl J Med 1990;323:713-719.
23. KIESS W, REICH A, MEYER K, GLASOW A, DEUTSCHER J, KLAMMT J, YANG Y, MÜLLER G, KRATZSCH J. A role for leptin in sexual maturation and puberty? Horm Res 1999;51(Suppl. 3):55-63.
24. TEIRMAA T, LUUKKAA V, ROUROU J, KOULU M, HUUPPONEN R. Correlation between circulating leptin and LH during the menstrual cycle in normal-weight women. Eur J Endocrinol 1998;139:190-194.
25. PERRONE L, PERROTTA S, RAIMONDO P, MUCERINO J, DE ROSA C, SICILIANI MC, SANTORO N, DEL GIUDICE EM. Inappropriate leptin secretion in Thalassaemia: a potential cofactor of pubertal timing derangement. J Pediatr Endocrinol Metab 2003;16:877-881.
26. DEDOUSIS GVZ, KYRTSONIS MC, ANDRIKOPOULOS NE, VOSKARIDOU E, LOUTRADIS A. Inverse correlation of plasma leptin and soluble transferrin receptor levels in β-thalassaemia patients. Ann Hematol 2002;81:543-547.
27. SKORDIS N, GOURNI M, KANARIS C, TOUMBA M, KLEANTHOUS M, KARATZIA N, PAVLIDES N, ANGASTINIOTIS M. The impact of iron overload and genotype on gonadal function in women with Thalassaemia major. Pediatr Endocrinol Rev 2004;2(Suppl.2):292-295.
28. CHERN JPS, LIN KH, TSAI WY, WANG SC, LU MY, LIN DT, LO SH. Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion dependent beta-Thalassaemia. J Pediatr Hematol Oncol 2003;25:880-884.
29. VOSCARIDOU E, TERPOS E. New insights into the pathophysiology and management of osteoporosis in patients with beta Thalassaemia. Br J Haematol 2004;127:127-139.
30. MYLONA M, LEOTSINIDES M, ALEXANDRIDES T, ZOUMBOS N, DIMOPOULOS PA. Comparison of DXA, QCT and trabecular structure in beta-Thalassaemia. Eur J Hematol 2005;74:430-437.
31. BIELINSKI BK, DARBYSHIRE PJ, MATHERS L, CRABTREE NJ, KIRK JM, STIRLING HF, SHAW NJ. Impact of disordered puberty on bone metabolism in beta-Thalassaemia major. Br J Haematol 2003;120:353-358.
32. MORABITO N, GAUDIO A, LASCO A, ATTERITANO M, PIZZOLEO MA, CINCOTTA M, LA ROSA M, GUARINO R, MEO A, FRISINA N. Osteoprotegerin and RANKL in the pathogenesis of Thalassaemia induced osteoporosis: new pieces of the puzzle. J Bone Miner Res 2004;19:722-777.
33. LASCO A, MORABITO N, GAUDIO M, BUENI M, WASNIEWAKA M, FRISINA N. Effects of hormonal replacement therapy on bone metabolism in young adults with beta-Thalassaemia major. Osteoporos Int 2001;12:570-575.
34. RAIOLA G, GALATI MC, DE SANCTIS V, CARUSO-NICOLETTI M, PINTOR C, DE SIMONE M, ARCURI VM, ANASTASI S. Growth and puberty in Thalassaemia major. J Pediatr Endocrinol Metab 2003;16:259-266.
35. WONKE B, DE SANCTIS V. Clinical aspects of transfusional iron overload. Rev Clin Exp Hematol 2000;4:322-335.